A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer
Clinical trial NCT07406542 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07406542
- Sponsor
- CSPC Megalith Biopharmaceutical Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-04-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.